最新ニュース CD Projekt (OTC:OTGLY) 株価情報

CD Projekt SA is the holding company of CD Projekt capital group. The firm with its subsidiary develops and publishes videogames for hardware platforms such as Steam, PlayStation Store, Xbox Games Store, Nintendo, App Store, Humble Bundle, Origin, and its own proprietary GOG.com platform. It is also involved in global digital videogame distribution. The firm has CD Projekt Red and GOG.com segments. It derives the majority of its revenues from CD Projekt Red segment.

CD Projekt SA

China Yuchai Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CYD#NYSE">CYD</a>) reported quarterly earnings of $1.14 per share. This is a 15.15 percent increase over earnings of $0.99 per share from the same period last year. The company reported $2.66 billion in sales this quarter. This is a 4.47 percent increase over sales of $2.55 billion the same period last year.

Earnings

News

China Yuchai Intl FY GAAP EPS $1.14 Up From $0.99 YoY, Sales $2.66B Up From $2.55B YoY

Smith & Nephew FY Sales $5.810B

Earnings Beats

ALLT

Allot Q4 2024 Adj. EPS $0.05 Up From $(0.43) YoY, Sales $24.906M Beat $24.400M Estimate

Contracts

Tutor Perini-Nan JV Bags Additional $232M For The Apra Harbor Waterfront Repairs

Carter's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRI#NYSE">CRI</a>) reported quarterly earnings of $2.39 per share which beat the analyst consensus estimate of $1.92 by 24.48 percent. This is a 13.41 percent decrease over earnings of $2.76 per share from the same period last year. The company reported quarterly sales of $859.712 million which beat the analyst consensus estimate of $837.575 million by 2.64 percent. This is a 0.22 percent increase over sales of $857.864 million the same period last year.

Carter's Q4 2024 Adj. EPS $2.39 Beats $1.92 Estimate, Sales $859.712M Beat $837.575M Estimate

Amer Sports (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AS#NYSE">AS</a>) reported quarterly earnings of $0.17 per share which met the analyst consensus estimate. This is a 254.55 percent increase over losses of $(0.11) per share from the same period last year. The company reported quarterly sales of $1.636 billion which beat the analyst consensus estimate of $1.600 billion by 2.27 percent. This is a 24.41 percent increase over sales of $1.315 billion the same period last year.

Amer Sports Q4 2024 Adj. EPS $0.17, Inline, Sales $1.636B Beat $1.600B Estimate

General

HITI

High Tide Pauses Acquisition Of Purecan GmbH And Sees For Alternative Arrangements Enter The German Medical Cannabis Market

WIIM

BITF

CLSK

COIN

HIVE

MARA

MSTR

RIOT

Shares of crypto miners and Bitcoin-linked stocks are trading lower after Bitcoin fell below $90,000.

Jefferies analyst Christopher Mandeville maintains Sprouts Farmers Market (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SFM#NASDAQ">SFM</a>) with a Hold and raises the price target from $119 to $139.

Price Target

Analyst Ratings

Jefferies Maintains Hold on Sprouts Farmers Market, Raises Price Target to $139

Health Care

NTRA

Natera Meets Coverage Requirements For Signatera For Surveillance In Lung Cancer

Fiscal 2025 Guidance The company provides the following guidance for fiscal 2025, a 52-week year compared to fiscal 2024, a 53-week year:
<ul>
<li>Total sales growth of approximately 2.8%</li>
<li>Comparable sales growth of approximately 1.0% for the comparable 52-week period</li>
<li>Approximately 13 new stores</li>
<li>Gross margin of approximately 33.4%</li>
<li>Operating margin of approximately 13.0%</li>
<li>Adjusted(1) operating margin of approximately 13.4%</li>
<li>Tax rate of approximately 24.5%</li>
<li>Net interest expense of approximately $2.2 billion</li>
<li>Diluted earnings-per-share to decline approximately 3% from $14.91 in fiscal 2024</li>
<li>Adjusted(1) diluted earnings-per-share to decline approximately 2% from $15.24 in fiscal 2024</li>
<li>Capital expenditures of approximately 2.5% of total sales</li>
</ul>

Guidance

Home Depot FY25 Outlook: Adj. EPS $14.94 vs $15.57 Est

Armstrong World Indus Sees FY25 Adj EPS Guidance Of $6.85-$7.15 Vs $6.87 Est, Net Sales Of 	$1.57B-$1.61B Vs. $1.54B Est.

2025 Financial Guidance
Henry Schein today provided financial guidance for 2025. Guidance is for current continuing operations as well as announced acquisitions and does not include the impact of restructuring and integration expenses, amortization expense of acquired intangible assets, any potential insurance claim recovery associated with the cybersecurity incident and costs associated with shareholder advisory matters. This guidance also assumes that foreign currency exchange rates remain generally consistent with 2024 levels and modest improvement in the dental and medical markets during the year.
<ul>
<li>2025 non-GAAP diluted EPS attributable to Henry Schein, Inc. is expected to be $4.80 to $4.94, reflecting growth of 1% to 4% compared with 2024 non-GAAP diluted EPS of $4.74.</li>
<li>2025 total sales growth is expected to be approximately 2% to 4% over 2024.</li>
<li>2025 Adjusted EBITDA3 growth is expected to increase mid-single digits compared with 2024.</li>
</ul>

Large Cap

HSIC

Henry Schein Forecasts 2025 Adjusted EPS Of $4.80-$4.94 Versus Consensus Of $5.01, With Sales Growth Of Approximately 2%-4% Over 2024

Tempus AI shares are trading lower after the company reported Q4 financial results and missed revenue estimates.

Hims & Hers Health, Inc. Class A Common Stock

HIMS

Hims & Hers Health shares are trading lower after the company reported Q4 financial results.

2025 Financial Guidance1
<figure class="table"> 
<table>
<tbody>
<tr>
<td colspan="1" rowspan="1">Financial Metric</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">Full Year 2025 Guidance</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Revenues</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">(2)% to flat from FY 2024</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Adjusted EBITDA Margin1</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">62.5% to 63.5%</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Capital expenditures</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$155 million to $165 million</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Effective tax rate</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">25% to 28%</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Free Cash Flow</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$(65) to $(75) million</td>
</tr>
</tbody>
</table>
</figure>

MPLN

Claritev (MultiPlan) 2025 Outlook: Expects Revenues To Be (2)% To Flat YoY, And Sees Adj. EBITDA Margin Of 62.5%-63.5%

Home Depot FY25 Outlook: GAAP EPS $14.46 vs $15.55 Est; Sales $163.980B vs $164.17B Est

IART

Integra LifeSciences  Sees Q1 Revenue Of $375M - $385M Vs. $411.71M Est; Adj EPS Of $0.40 - $0.45 Vs. $0.56 Est.

LivaNova (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIVN#NASDAQ">LIVN</a>) is looking for FY2025 Adj EPS of $3.65-$3.75 vs $3.63 analyst estimate..

LIVN

LivaNova Sees FY2025 Adj EPS $3.65-$3.75 vs $3.63 Est; Revenue to grow between 5.0% and 6.0% on a constant-currency basis.

Integra LifeSciences Sees FY15 Adj EPS Of $2.41 - $2.51 Vs. $2.51 Est.

CD Projekt

Comments

CD Projekt

ニュース

最新ニュース CD Projekt (OTC:OTGLY) 株価情報

ニュース

パートナーシップ

ベンジンガ・グローバル